Stephen Simpson, CFA
Long only, growth at reasonable price, value, research analyst

For Teleflex, Small Things Add Up

If companies like Intuitive Surgical and Heartware live on the "gee whiz" end of the med-tech spectrum, Teleflex (NYSE:TFX) is on the other end. That is not to say that there isn't meaningful R&D and engineering going into the company's products, but categories like central venous catheters, PICCs, Foley catheters, and endotracheal tubes just don't tend to get growth-oriented med-tech investors all that excited.

Even so, Teleflex has a lot going for it. The company has been a very willing acquirer and increased investments in R&D should lead the way to more innovative new products and market share growth. In the meantime, management is focused on operating improvements that should support double-digit earnings growth. While Teleflex does not...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details